期刊文献+

代谢综合征患者血清Apelin水平的变化 被引量:4

The change of serum apelin's level in metabolic syndrome
暂未订购
导出
摘要 目的:探讨代谢综合征(MS)患者血清Apelin水平的变化。方法:69例MS患者和63例正常糖调节(NGR)者,采用酶联免疫吸附法测定空腹血清Apelin含量,同时检测空腹血糖和胰岛素水平,以稳态模型评价胰岛素抵抗指数(HOMA-IR)。结果:MS组血清Apelin水平明显升高,确诊2型糖尿病MS组明显高于糖调节受损的MS组(475.8±37.3vs451.5±54.7)ng/L(P<0.05)和超重/肥胖者(475.8±37.3vs430.3±52.1)ng/L(P<0.01),且均高于NC组。多元逐步回归分析结果示:ln(HOMA-IR)、BMI和TC是血清Apelin独立相关因素(r2分别为0.459、0.494、0.293,均P<0.05)。结论:MS中多种代谢成分异常与血清Apelin升高密切相关,其可能是由于胰岛素抵抗加重所致。 Objective To investigate the changes of the serum apelin level in patients with metabolic syndrome. Methods Fasting plasma glucose (FPG) and insulin would be determined in order to evluate HOMA insulin resistance (HOMA-IR), The level of fasting serum apelin was detected by ELISA assay. Meanwhile, the height, weight, waist circumference, blood pressure, HbA1C and lipid profile level were also measured. ResultsThe result showed that the level of serum apelin in MS I group was higher obviously in both MS II and overweight/ obesity groups than the control group (P 〈 0.01 ). Moreover the level of serum apelin of metabolic syndrome with type 2 diabetes mellitus (475.8 ± 37.3)ng/L was higher than the metabolic syndrome with impaired glucose regulation(451.5±54.7)ng/L(P 〈 0.05) and the group of overweight/obesity 430.3± 52.1 )ng/L(P 〈 0.01 ). The differences had signifance in statistics. In a multiple step-wise regression analysis, in (HOMA-IR), BMI and TC were independent factors related to apelin (r2=0.544, r2 = 0.494, r2 = 0.293, all P 〈 0.05). Conclusion The increased of serum apelin level is closely related to overweight/obesity, diabetes/impaired glucose regulation, hypertension, dyslipidemia and other metabolic abnormalities of metabolic syndrome, which maybe the increased insulin resistance that caused the level of serum apelin increased in the patients with MS group.
出处 《实用医学杂志》 CAS 北大核心 2012年第6期910-912,共3页 The Journal of Practical Medicine
基金 广西壮族自治区卫生厅科研课题(编号:桂卫Z2007080)
关键词 糖尿病 2型 APELIN 代谢综合征 肥胖 胰岛素抵抗 血脂代谢 Apelin Metabolic syndrome Insulin resistance Type 2 diabetes mellitus Lipidmetabolism
  • 相关文献

参考文献12

  • 1Tatemoto K,Hosoya M,Habata Y,et al.Isolation and characteization of a novel endogenous peptide ligand for the human APJ receptor[J].Biochem Biophysi Res Commun,1998,251(2):471-476.
  • 2Lee D K,George S R,ODowd B F.Unravelling the roles of the Apelin system:prospective therapeutic applications in heart failure and obesity[J].Trends Pharmacol Sci,2006,27(4):190-194.
  • 3中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3089
  • 4World Health Organization.Department of Noncommunicable disease Surveillance.Definition,diagnosis and classification of diabetes mellitus and its complication.Report of a WHO consultation.Part1:Diagnosis and Clussification.Geneva:WHO,1999.
  • 5Boucher J,Masri B,Daviand D,et al.Apelin,a newly identified adipokine up-regulated by insulin and obesity[J].Endocrinology,2005,146(4):1764-1771.
  • 6Wei L,Hou X,Tetomoto K.Regulation of Apelin mRNA expression by insulin and glucocorticoids in mouse 3T3-L1 adipocytes[J].Regul Pept,2005,132(1-3):27-32.
  • 7魏丽,侯兴华,贾伟平.胰岛素上调3T3-L1细胞apelin基因表达的初步观察[J].中华内分泌代谢杂志,2006,22(4):384-385. 被引量:7
  • 8Sorhede Winzell M,Magnusson C,Ahren B.The apj receptor is expressed in pancreatic islet and its ligand,Apelin,inhibits insulin secretion in mice[J].Regul Pept,2005,131(1/3):12-17.
  • 9黎英荣,连莲,苏宏业,潘海林,夏宁,肖常青.肥胖2型糖尿病患者血清Apelin水平的变化及其意义[J].广西医学,2009,31(5):631-632. 被引量:9
  • 10Heinonen M V,Purhonen A K,Miettinen P,et al.Apelin,orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding[J].Regul Pept,2005,130(1-2):7-13.

二级参考文献29

  • 1魏丽,侯兴华,贾伟平.胰岛素上调3T3-L1细胞apelin基因表达的初步观察[J].中华内分泌代谢杂志,2006,22(4):384-385. 被引量:7
  • 2Boucher J,Masri B,Daviaud D,et al.Apelin,a newly identified adipokine up-regulated by insulin and obesity[J].Endocrinology,2005,146(4):1 764-1 771.
  • 3Sorhede-Winzell M,Magnusson C,Ahren B.The APJ receptor is expressed in pancreatic islets and its ligand,apelin,inhibits insulin secretion in mice[J].Regul Pept,2005,131(1-3):12-17.
  • 4Tatemoto K,Hosoya M,Habata Y,et al.Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor[J].Biochem Biophy Res commun,1998,251(2):471-476.
  • 5Heinonen MV,Purhonen AK,Miettinen P,et al.Apelin,orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding[J].Regul Pept,2005,130(1-2):7-13.
  • 6Tatemoto K, Hosoya M, Habata Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor.Biochem Biophys Res Commun, 1998,251:471-476.
  • 7Tatemoto K, Takayama K, Zou MX, et al. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Peptides, 2001,99:87-92
  • 8Friedman JM, Leibel RL. Tackling a weighty problem. Cell, 1992,69:217-220.
  • 9Boucher J, Masri B, Daviand D, et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology, 2005,146 : 1764-1771.
  • 10Szokodi I, Tavi P, Foldes G, et al. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res, 2002,91:434-440.

共引文献3129

同被引文献48

  • 1谭丽艳,齐亚灵,李洪源,徐海波.初诊老年肥胖2型糖尿病患者血清nesfatin-1及apelin水平与胰岛素抵抗的关系[J].中国老年学杂志,2014,34(8):2034-2035. 被引量:17
  • 2Jan Dada.一种新识别的脂肪细胞因子vaspin能改善葡萄糖耐量和胰岛素敏感性[J].中国分子心脏病学杂志,2005,5(5):752-752. 被引量:8
  • 3De Leo V, la Marca A, Petraglia F. Insulin-lowering agents in the management of polycystic ovary syndrome [ J ]. Endocr Rev, 2003,24 (5) : 633-667.
  • 4Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus [J]. Fertil Steril, 2002, 77(6) : 1095-1105.
  • 5Tatemoto K, Takayama K, Zou MX, et al. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism [J]. Regul Pept, 2001, 99(2-3) : 87-92.
  • 6Boucher J, Masri B, Daviaud D, et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity [J]. Endocrinology, 2005,146(4) : 1764-1771.
  • 7Cavallo MG. Altered glucose homeostasis is associated with increased serum apelin levels in type 2 diabetes mellitus [J]. PLoS One, 2012,7(12) : e51236.
  • 8Shimizu T, Kosaka N, Murayama C, et al. Apelin and APJ receptor expression in granulosa and theca cells during different stages of follicular development in the bovine ovary : Involvement of apoptosis and hormonal regulation [J]. Anim Reprod Sci, 2009,116(1-2) : 28-37.
  • 9Schilffarth S, Antoin B, Schams D. The expression of apelin and its receptor APJ during different physiological stages in the bovine ovary [J]. Int J Biol Sci, 2009,5(4) : 344-350.
  • 10Chun HJ, Ali ZA, Kojima Y, et al. Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis [J]. J Clin Invest, 2008,118(10) : 3343-3354.

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部